TRANSPLANT-RELATED DISORDER
Clinical trials for TRANSPLANT-RELATED DISORDER explained in plain language.
Never miss a new study
Get alerted when new TRANSPLANT-RELATED DISORDER trials appear
Sign up with your email to follow new studies for TRANSPLANT-RELATED DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New model may predict and prevent deadly transplant complication
Disease control Not yet recruitingThis study tests whether giving the drug ruxolitinib early can prevent severe graft-versus-host disease (GvHD) in people getting a stem cell transplant. About 438 adults at intermediate-to-high risk, as identified by a special model called daGOAT, will be enrolled. The goal is to…
Matched conditions: TRANSPLANT-RELATED DISORDER
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Radioactive antibody could boost stem cell transplant success in tough leukemia
Disease control Not yet recruitingThis study tests a new approach for people with relapsed or refractory acute myeloid leukemia (AML) who have active disease. Before a stem cell transplant, patients receive a radioactive antibody (131I-apamistamab) along with chemotherapy and low-dose radiation to prepare the bod…
Matched conditions: TRANSPLANT-RELATED DISORDER
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 16:44 UTC